• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高纤维饮食与克罗恩病:系统评价和荟萃分析。

High-Fiber Diet and Crohn's Disease: Systematic Review and Meta-Analysis.

机构信息

Facultad de Fisioterapia y Enfermería, Universidad de Castilla-La Mancha, 45071 Toledo, Spain.

Hospital Universitario de Toledo, 45007 Toledo, Spain.

出版信息

Nutrients. 2023 Jul 12;15(14):3114. doi: 10.3390/nu15143114.

DOI:10.3390/nu15143114
PMID:37513532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10384554/
Abstract

Crohn's disease (CD) is a subtype of inflammatory bowel disease (IBD). CD is a health problem in Western countries such as the US and European nations and is an idiopathic disease; however, certain cases of CD have been associated with intestinal dysbiosis. A systematic review with a meta-analysis was carried out to determine the efficacy of a diet rich in fiber with or without cointervention to improve remission rates for CD. The literature in the PubMed, Scopus, Web of Science, and ClinicalTrials databases was reviewed. The quality of the studies was evaluated using the Johanna Briggs Institute (JBI) scale. This review was conducted in accordance with the structure outlined in the PRISMA statement. In addition, a meta-analysis was performed with a 95% confidence interval (CI) and a random effects model. Eleven studies were included, totaling 2389 patients with CD. Applying a diet rich in fiber with or without the administration of routine therapies improved CD remission rates. Data regarding CD activity, remission time, and adverse effects derived from fiber consumption were analyzed. Consumption of fiber in the diet could improve remission rates for CD patients who receive or do not receive other treatment to maintain remission.

摘要

克罗恩病(CD)是炎症性肠病(IBD)的一种亚型。CD 是西方国家(如美国和欧洲国家)的健康问题,是一种特发性疾病;然而,某些 CD 病例与肠道菌群失调有关。进行了一项系统评价和荟萃分析,以确定富含纤维的饮食是否联合或不联合其他干预措施来提高 CD 的缓解率。对 PubMed、Scopus、Web of Science 和 ClinicalTrials 数据库中的文献进行了回顾。使用 Johanna Briggs 研究所(JBI)量表评估研究的质量。本综述按照 PRISMA 声明中概述的结构进行。此外,还进行了荟萃分析,置信区间(CI)为 95%,采用随机效应模型。纳入了 11 项研究,共有 2389 例 CD 患者。应用富含纤维的饮食,无论是否联合常规治疗,均可提高 CD 的缓解率。分析了纤维摄入对 CD 活动、缓解时间和不良反应的数据。饮食中摄入纤维可以提高接受或不接受其他维持缓解治疗的 CD 患者的缓解率。

相似文献

1
High-Fiber Diet and Crohn's Disease: Systematic Review and Meta-Analysis.高纤维饮食与克罗恩病:系统评价和荟萃分析。
Nutrients. 2023 Jul 12;15(14):3114. doi: 10.3390/nu15143114.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
4
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3.
5
Enteral nutritional therapy for inducing remission of Crohn's disease.诱导克罗恩病缓解的肠内营养疗法。
Cochrane Database Syst Rev. 2001(3):CD000542. doi: 10.1002/14651858.CD000542.
6
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2006 Jul 19(3):CD006097. doi: 10.1002/14651858.CD006097.
7
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.对病情缓解的克罗恩病患者停用免疫抑制剂或生物疗法。
Cochrane Database Syst Rev. 2018 May 12;5(5):CD012540. doi: 10.1002/14651858.CD012540.pub2.
8
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD000542. doi: 10.1002/14651858.CD000542.pub2.
9
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD006097. doi: 10.1002/14651858.CD006097.pub2.
10
Aminosalicylates for induction of remission or response in Crohn's disease.用于诱导克罗恩病缓解或反应的氨基水杨酸盐。
Cochrane Database Syst Rev. 2016 Jul 3;7(7):CD008870. doi: 10.1002/14651858.CD008870.pub2.

引用本文的文献

1
Role of the Dietitian in the Inflammatory Bowel Disease Multidisciplinary Team.营养师在炎症性肠病多学科团队中的作用。
J Gastroenterol Hepatol. 2025 Sep;40(9):2190-2196. doi: 10.1111/jgh.70001. Epub 2025 Jul 10.
2
Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions.炎症性肠病的饮食干预与口服营养补充:当前证据与未来方向
Nutrients. 2025 May 30;17(11):1879. doi: 10.3390/nu17111879.
3
Specific Composition Diets and Improvement of Symptoms of Immune-Mediated Inflammatory Diseases in Adulthood-Could the Comparison Between Diets Be Improved?

本文引用的文献

1
Relapse-Free Course in Nearly Half of Crohn's Disease Patients With Infliximab and Plant-Based Diet as First-Line Therapy: A Single-Group Trial.近半数克罗恩病患者采用英夫利昔单抗联合植物性饮食作为一线治疗可实现无复发病程:一项单组试验。
Perm J. 2022 Jun 29;26(2):40-53. doi: 10.7812/TPP/21.073. Epub 2022 Jun 15.
2
The Effect of Dietary Interventions on Chronic Inflammatory Diseases in Relation to the Microbiome: A Systematic Review.膳食干预对与微生物组相关的慢性炎症性疾病的影响:系统评价。
Nutrients. 2021 Sep 15;13(9):3208. doi: 10.3390/nu13093208.
3
The complex relationship between diet, symptoms, and intestinal inflammation in persons with inflammatory bowel disease: The Manitoba Living With IBD Study.
特定成分饮食与成人免疫介导炎症性疾病症状的改善——饮食之间的比较能否改进?
Nutrients. 2025 Jan 29;17(3):493. doi: 10.3390/nu17030493.
4
Adjunct Therapies to Standard Care for IBS and IBD Patients: Digestive Symptoms Improvement and Quality of Life Optimization.IBS 和 IBD 患者标准治疗的辅助治疗:改善消化症状和优化生活质量。
Nutrients. 2024 Nov 18;16(22):3927. doi: 10.3390/nu16223927.
5
The Role of Environmental and Nutritional Factors in the Development of Inflammatory Bowel Diseases: A Case-Control Study.环境和营养因素在炎症性肠病发展中的作用:病例对照研究。
Nutrients. 2024 Jul 29;16(15):2463. doi: 10.3390/nu16152463.
6
Explainable AI-prioritized plasma and fecal metabolites in inflammatory bowel disease and their dietary associations.炎症性肠病中可解释人工智能优先考虑的血浆和粪便代谢物及其饮食关联
iScience. 2024 Jun 17;27(7):110298. doi: 10.1016/j.isci.2024.110298. eCollection 2024 Jul 19.
7
DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering.减轻炎症性肠病:灭火并防止病情隐匿发展
Dig Dis Sci. 2025 Jan;70(1):49-73. doi: 10.1007/s10620-024-08523-5. Epub 2024 Jul 4.
8
Dietary Fiber in Inflammatory Bowel Disease: Are We Ready to Change the Paradigm?炎症性肠病中的膳食纤维:我们准备好改变范式了吗?
Nutrients. 2024 Apr 10;16(8):1108. doi: 10.3390/nu16081108.
炎症性肠病患者饮食、症状与肠道炎症之间的复杂关系:曼尼托巴炎症性肠病生活研究
JPEN J Parenter Enteral Nutr. 2022 May;46(4):867-877. doi: 10.1002/jpen.2257. Epub 2021 Sep 23.
4
Systematic review with meta-analysis: dietary intake in adults with inflammatory bowel disease.系统评价与荟萃分析:炎症性肠病成人的饮食摄入。
Aliment Pharmacol Ther. 2021 Sep;54(6):742-754. doi: 10.1111/apt.16549. Epub 2021 Jul 29.
5
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.西班牙炎症性肠病的发病率、临床特征及管理:大规模流行病学研究
J Clin Med. 2021 Jun 29;10(13):2885. doi: 10.3390/jcm10132885.
6
Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User's Guide for Adult and Pediatric Gastroenterologists.炎症性肠病初诊患者的处理方法:成人和儿科胃肠病学家的使用指南。
Gastroenterology. 2021 Jul;161(1):47-65. doi: 10.1053/j.gastro.2021.04.063. Epub 2021 Apr 30.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
Functional Food Components, Intestinal Permeability and Inflammatory Markers in Patients with Inflammatory Bowel Disease.功能性食品成分、肠道通透性和炎症标志物在炎症性肠病患者中的变化。
Nutrients. 2021 Feb 16;13(2):642. doi: 10.3390/nu13020642.
9
Dietary fibre in gastrointestinal health and disease.膳食纤维与胃肠道健康和疾病。
Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):101-116. doi: 10.1038/s41575-020-00375-4. Epub 2020 Nov 18.
10
Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases.膳食补充剂在炎症性肠病及相关自身免疫性疾病中的疗效。
Nutrients. 2020 Jul 20;12(7):2156. doi: 10.3390/nu12072156.